Published in Kidney Int on March 11, 2009
Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats. Am J Physiol Renal Physiol (2012) 0.89
Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. Cardiol Res Pract (2010) 0.86
Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int (2009) 0.82
Biomarkers in kidney fibrosis: are they useful? Kidney Int Suppl (2011) (2014) 0.81
Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr Nephrol (2010) 0.81
Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol (2012) 0.81
Hemocyanins Stimulate Innate Immunity by Inducing Different Temporal Patterns of Proinflammatory Cytokine Expression in Macrophages. J Immunol (2016) 0.78
Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget (2016) 0.78
HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy. Am J Pathol (2015) 0.77
Donor race and outcomes in kidney transplant recipients. Clin Transplant (2012) 0.76
Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS One (2016) 0.76
Clinical Relevance of Transforming Growth Factor-β1, Interleukin-6 and Haptoglobin for Prediction of Obesity Complications in Prepubertal Egyptian Children. Open Access Maced J Med Sci (2015) 0.75
A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy. Can J Kidney Health Dis (2016) 0.75
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A (1999) 3.19
Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int (2006) 2.85
Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell (2006) 2.84
Ethnic differences in the association between body mass index and hypertension. Am J Epidemiol (2002) 2.63
Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem (1991) 2.52
Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int (2004) 2.44
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev (1999) 2.22
Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci U S A (1997) 2.14
sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels. J Biol Chem (1999) 2.04
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (1998) 1.90
Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A (2000) 1.86
Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients. Kidney Int (1998) 1.66
Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol (2007) 1.64
Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest (1993) 1.40
Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.33
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology (1999) 1.28
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Plasma renin activity and plasma prorenin assays. Clin Chem (1991) 1.16
Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol (2002) 1.12
Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am J Physiol Renal Physiol (2008) 1.09
Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism (2005) 1.08
Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause (2007) 1.06
Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. Am J Kidney Dis (2008) 1.02
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol (2004) 1.02
Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells. Kidney Int (2006) 1.01
Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med (2006) 1.01
Why is plasma renin activity lower in populations of African origin? J Hum Hypertens (2001) 0.94
The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypertens (1996) 0.92
Transforming growth factor-beta is a renin secretagogue at picomolar concentrations. Am J Physiol (1993) 0.92
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. Blood Press (2003) 0.87
Hypertension in minority populations. J Clin Hypertens (Greenwich) (2006) 0.84
Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. Am J Hypertens (2002) 0.84
Perspectives on blockade of TGFbeta overexpression. Kidney Int (2006) 0.84
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86
Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation (2003) 7.68
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Patient compliance with paper and electronic diaries. Control Clin Trials (2003) 4.80
Patient non-compliance with paper diaries. BMJ (2002) 4.50
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
A snapshot of the age distribution of psychological well-being in the United States. Proc Natl Acad Sci U S A (2010) 3.67
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96
Ectopic expression of BABY BOOM triggers a conversion from vegetative to embryonic growth. Plant Cell (2002) 2.95
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med (2006) 2.68
Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58
Masked hypertension. Hypertension (2002) 2.57
The accuracy of pain and fatigue items across different reporting periods. Pain (2008) 2.57
CLV3 is localized to the extracellular space, where it activates the Arabidopsis CLAVATA stem cell signaling pathway. Plant Cell (2002) 2.52
Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom Med (2006) 2.52
Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. J Neurosurg (2012) 2.37
Intensive momentary reporting of pain with an electronic diary: reactivity, compliance, and patient satisfaction. Pain (2003) 2.36
MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum (2009) 2.33
Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens (2008) 2.31
Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull (2005) 2.26
Large ventral lateral neurons modulate arousal and sleep in Drosophila. Curr Biol (2008) 2.26
Losing life and livelihood: a systematic review and meta-analysis of unemployment and all-cause mortality. Soc Sci Med (2011) 2.23
Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry (2010) 2.15
Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med (2010) 2.12
The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med (2007) 2.08
Age-specific cerebral perfusion pressure thresholds and survival in children and adolescents with severe traumatic brain injury*. Pediatr Crit Care Med (2014) 2.07
Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06
Would you perform thrombolysis in this acute ischemic stroke patient? Arch Neurol (2009) 2.03
Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens (2012) 2.01
Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00
Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98
Circadian- and light-dependent regulation of resting membrane potential and spontaneous action potential firing of Drosophila circadian pacemaker neurons. J Neurophysiol (2007) 1.94
Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med (2011) 1.93
Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens (2008) 1.91
Consistency of blood pressure differences between the left and right arms. Arch Intern Med (2007) 1.89
Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics (2009) 1.88
Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83
Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res (2008) 1.78
The E3 ubiquitin ligase BIG BROTHER controls arabidopsis organ size in a dosage-dependent manner. Curr Biol (2006) 1.77
Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping. Am J Hypertens (2009) 1.75
Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India. Am J Trop Med Hyg (2005) 1.73
Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation (2005) 1.67
Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain (2004) 1.66
Racism and ambulatory blood pressure in a community sample. Psychosom Med (2007) 1.64
Personality and mortality risk across the life span: the importance of conscientiousness as a biopsychosocial attribute. Health Psychol (2007) 1.62
A population approach to the study of emotion: diurnal rhythms of a working day examined with the Day Reconstruction Method. Emotion (2006) 1.62
Deceased-donor kidney transplantation: improvement in long-term survival. Nephrol Dial Transplant (2010) 1.60
Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med (2003) 1.60
Multiplex fluorogenic real-time PCR for detection and quantification of Escherichia coli O157:H7 in dairy wastewater wetlands. Appl Environ Microbiol (2002) 1.60
Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people. Cochrane Database Syst Rev (2012) 1.59
Sustained blood pressure increase after an acute stressor: the effects of the 11 September 2001 attack on the New York City World Trade Center. J Hypertens (2005) 1.58
Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich) (2010) 1.57
Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension (2009) 1.57
Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens (2009) 1.57
Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension (2006) 1.56
Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension (2008) 1.54
Arterial stiffness in chronic inflammatory diseases. Hypertension (2005) 1.53
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol (2005) 1.51
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol (2003) 1.50
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48
Single-day pain assessments as clinical outcomes: not so fast. Clin J Pain (2014) 1.47
Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: the CARDIA Study (USA). Soc Sci Med (2005) 1.46
Observed hostility and the risk of incident ischemic heart disease: a prospective population study from the 1995 Canadian Nova Scotia Health Survey. J Am Coll Cardiol (2011) 1.46
Effect of doxazosin on the left ventricular structure and function in morning hypertensive patients: the Japan Morning Surge 1 study. J Hypertens (2008) 1.45
Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res (2003) 1.45
Direct transport within an organized state trauma system reduces mortality in patients with severe traumatic brain injury. J Trauma (2006) 1.42
Prevalence of metabolic syndrome and obesity in renal transplanted Mexican children. Pediatr Transplant (2008) 1.42
Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke (2011) 1.42
Modifications of coronary risk factors. Am J Cardiol (2006) 1.41